Mason Vialonga

Department of Orthopedic Surgery, Cooperman Barnabas Medical Center/Jersey City Medical Center, RWJBarnabas Health, Livingston and Jersey City, New Jersey, USA.

6 publications 2021 – 2026

What does Mason Vialonga research?

Mason Vialonga studies the treatment of large artery aneurysms, which are dangerous enlargements of blood vessels that can lead to serious health risks if not properly managed. His research highlights the complications that can arise after minimally invasive treatments, such as when an aneurysm re-expands after initial repair. By investigating cases where these techniques fail, he aims to improve surgical strategies and outcomes for patients who may require additional surgeries to address these complications.

Key findings

  • In one case, a 20 centimeter common iliac artery aneurysm re-expanded nine years after a minimally invasive repair, demonstrating potential long-term risks associated with endovascular treatments.
  • The study emphasizes that endovascular repairs can fail years after the procedure, necessitating open surgical interventions.
  • The need for open surgery was confirmed as a safe and necessary option for patients experiencing re-expansion of previously treated aneurysms.

Frequently asked questions

Does Dr. Vialonga study aneurysms?
Yes, he focuses on the treatment and complications associated with artery aneurysms.
What types of surgical techniques has Dr. Vialonga researched?
He has researched both minimally invasive approaches and open surgical repairs for aneurysms.
Is Dr. Vialonga's work relevant to patients with vascular conditions?
Yes, his studies provide important insights for patients dealing with complications from aneurysms and the risks associated with treatment failures.

Publications in plain English

Arthroscopic Rotator Cuff Repair Reinforced With Proximal Biceps Rerouting.

2026

Video journal of sports medicine

Salandra JM, Ayhan E, Vialonga M, Moran J, Hsu JC

Plain English
This study looked at a new surgical technique that combines fixing a large rotator cuff tear with rerouting the biceps tendon. The results showed that this method led to lower retear rates and improved outcomes, with one patient experiencing complete pain relief and full strength return within six months. This matters because it provides a more effective and cost-efficient option for active patients who haven't improved with other treatments. Who this helps: Patients with massive rotator cuff tears who are seeking relief and improved shoulder function.

PubMed

Early versus Standard Weight Bearing Following Operative Treatment of Tibial Plateau Fractures: Do We Really Have to Wait So Long?

2024

The journal of knee surgery

Heiman E, Menken LG, Tang A, Vialonga M, Jankowski JM +2 more

Plain English
This study looked at how soon patients can start putting weight on their legs after surgery for tibial plateau fractures. It compared two groups: one that began weight-bearing in less than 10 weeks (6.5 weeks on average) and another that waited longer than 10 weeks (11.8 weeks). The results showed that those who started earlier could begin bearing weight significantly sooner without any differences in healing time or complications. Who this helps: This research benefits patients recovering from tibial plateau fractures by potentially allowing them to regain mobility faster.

PubMed

Survivorship Analysis in Asymptomatic COVID-19+ Hip Fracture Patients: Is There an Increase in Mortality?

2022

Hip & pelvis

Vialonga MD, Menken LG, Tang A, Yurek JW, Sun L +3 more

Plain English
This study looked at hip fracture patients who tested positive for COVID-19 but showed no symptoms, comparing them to patients who tested negative. It found that the COVID-19-positive group had significantly higher death rates, with 26.7% dying within 30 days compared to just 6% in the negative group, and 41.7% versus 17.2% dying within 90 days. This matters because it highlights the additional risks that asymptomatic COVID-19 patients face when undergoing surgery, which could influence how healthcare providers manage these cases. Who this helps: This helps doctors and healthcare teams by informing them of the higher risks in treating hip fracture patients with asymptomatic COVID-19.

PubMed

Late Open Repair of a Massive Common Iliac Artery Aneurysm after Endovascular Failure.

2022

Annals of vascular surgery

Vialonga M, Grieff AN, Beckerman WE

Plain English
A patient who had a minimally invasive procedure to treat an artery aneurysm nine years earlier developed a massive new aneurysm (over 8 inches across) in the same location because the original treatment failed—fluid was leaking into the aneurysm sac and causing it to expand dangerously. The doctors had to perform open surgery to remove the aneurysm and tie off the damaged artery to fix the problem. This case shows that patients treated for large artery aneurysms with minimally invasive procedures need long-term follow-up care, since complications can emerge years later and become life-threatening.

PubMed

Acute Septic Carpal Tunnel Syndrome in a Rock Climber.

2021

Journal of orthopaedic case reports

Zbeda RM, Rabinovich RV, Vialonga M, Seigerman DA

Plain English
This study examined a case of a serious hand infection called acute septic carpal tunnel syndrome in a 33-year-old male rock climber. Four days after climbing indoors, he experienced numbness in his fingers and severe pain, which led to a confirmed deep infection and required immediate surgical treatment. The findings highlight the risk of hand infections in rock climbers, aiming to raise awareness and improve prevention and treatment for this specific injury. Who this helps: This benefits rock climbers and healthcare providers.

PubMed

Time to Improvement After Corticosteroid Injection for Trigger Finger.

2021

Cureus

Seigerman D, McEntee RM, Matzon J, Lutsky K, Fletcher D +3 more

Plain English
Researchers studied how well corticosteroid injections help people with trigger finger, a hand condition that causes pain and difficulty moving the fingers. Out of 452 patients, 82.4% felt complete pain relief within an average of 6.6 days after the injection, while 65.9% experienced relief from finger triggering after about 8.1 days. This is important because it shows that most patients can quickly find relief from their symptoms after the injection. Who this helps: This helps patients suffering from trigger finger.

PubMed

Publication data sourced from PubMed . Plain-English summaries generated by AI. Not medical advice.